RES could improve the symptom of NAFLD by protecting the liver, adjusting lipid metabolism, alleviating inflammation and fibrosis, regulating the oxidation equilibrium status, and enhancing autophagy [119, 120, 122] as well as controlling the farnesoid X receptor (FXR) [123]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.